About Motilent

Motilent develops medical imaging software that helps clinicians diagnose and monitor digestive diseases with greater precision. The company's platform, Entrolytics, combines secure data management with quantitative analysis tools, enabling hospitals and researchers to turn subjective imaging data into objective clinical scores that track disease activity. Motilent's technology supports conditions like Crohn's disease and inflammatory bowel disease, providing validated tools for clinical practice and trials. By making gastrointestinal imaging more measurable, the company helps clinicians make faster treatment decisions, supports research into new therapies, and improves outcomes for patients with digestive health challenges.